NCT02080468View on ClinicalTrials.gov

Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 19, 2014

Primary Completion Date

April 24, 2014

Study Completion Date

April 24, 2014

Conditions
Healthy
Interventions
DRUG

lomitapide

20 mg

DRUG

EE/norgestimate

1x0.035-mg EE/0.25-mg norgestimate tablet

Trial Locations (1)

75247

Covance Clinical Research Unit, Inc, Dallas

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT02080468 - Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects | Biotech Hunter | Biotech Hunter